Liaoning ChengDa Biotechnology Co., Ltd.
About us | Our company has adopted the advanced technology of high density microcarriers in bioreactors from BARI Consultant in the USA to produce vero cell rabies vaccines for human use and inactivated purified Japanese encephalitis vaccines. Located in Hunnan New District of Shenyang City, CDBIO has a production capability of 15,000,000 doses of rabies vaccines for human use and a production capability of 20,000,000 doses of inactivated purified Japanese encephalitis vaccines annually. Since 2005, CDBIO has passed the GMP validation issued by SFDA and has the right to sell rabies vaccine in China. Dr. Neol Miranda, representative of WHO in Asia, has visited CDBIO in May, 2005, and has given good evaluation on the manufacture of CDBIO. There are over 200 employees in CDBIO, 80 of them holding Bachelor's degrees, 6 of them holding Master's degrees and 1 of them holding Doctor's degrees. CDBIO has continued research on many kinds of vaccines on the basis of bioreactor technology. The sample of Japanese encephalitis vaccine has finished the clinical trials in 2005 and we will start to sell this vaccine at the end of 2006. Rabies vaccines for veterinary use will be produced in 2007. Furthermore, CDBIO will produce influenza vaccines, polio vaccines and several other vaccines in recent years. |
---|---|
Business Type | Manufacturer |
Business Role | Supplier |
Products/Services | Rabies vaccines, Japanese encephalitis vaccines and several other vaccines |
OEM Service | No |
Our Markets | Worldwide |
No. of Employees | 101 - 500 People |
No. of R&D Staff | 5 - 10 People |
Estimated Annual(Sales_USD) | US$10 Million - US$50 Million |
Export Percentage | 30% |
Quality_Control | In House & Third Parties |
Year Established | 2002 |
Legal Representative(CEO) | Zhuang Jiurong |
Factory Location | Xinfang Street, Hunnan New District, Shenyang City, Liaoning Province. China |
Factory Size | 15,000 |